InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
64,580.23
(
1.07%
)
Post# of 251718
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

dav1234

Send PM Follow Ignore
Followers 97
Posts 92809
Boards Moderated 4
Alias Born 10/29/2007

dav1234

Re: None

Thursday, 03/27/2014 8:24:44 AM

Thursday, March 27, 2014 8:24:44 AM

Post# of 251718
Exact Sciences halted ahead of FDA panel meeting for Cologuard
Exact Sciences' (EXAS) shares have been halted ahead of a meeting of an FDA committee to discuss the company's premarket approval application for its Cologuard screening test for colorectal cancer.
The panel is due to start the meeting at 8 am ET.
Trial results showed that compared with colonoscopy, the test is 92% sensitive for cancer stages I and II, and 69% for precancerous polyps containing high-grade dysplasia (highest cancer risk).
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up